Litigation Archives

Pharmalot Ed Silverman

A federal appeals court just slammed the door on Allergan’s deal with the Mohawk tribe

Pharmalot Ed Silverman

Aetna pressures whistleblower who alleged CVS Caremark ripped off Medicare

Pharmalot Ed Silverman

Pharmalittle: Amgen migraine drug costs less than expected; J&J halts development on Alzheimer’s drug

Pharmalot Ed Silverman

A reversal of fortunes: Judge voids order Gilead must pay $2.5B to Merck over a patent dispute

Pharmalot Ed Silverman

Pharmalittle: Supermarkets sue over generic price fixing; Daiichi can collect that $550 million award

Pharmalot Ed Silverman

Pharmalittle: Sanofi to refund Philippines for dengue vaccine; Google backs universal flu vaccine

Pharmalot Ed Silverman

Allergan may face a setback to its Mohawk deal thanks to a new ruling

Pharmalot Ed Silverman

Three more drug makers allegedly used nurses to promote medicines

Pharmalot Ed Silverman

Pharmalittle: Anthem to start its own PBM; J&J wins a big court reversal

Pharmalot Ed Silverman

Allergan to pay $4 million to settle sex discrimination charges by former sales reps

Pharmalot Ed Silverman

Pharmalittle: Shire CFO will be leaving; J&J hit with $417 million talc verdict

Pharmalot Ed Silverman

Pfizer must face NYU in a lawsuit over royalties on a cancer drug, again

Pharmalot Ed Silverman

Winners and losers: Who had a good week – and who didn’t

Pharmalot Ed Silverman

Glaxo fights a lawsuit that has all sorts of interesting twists

Pharmalot Ed Silverman

Drug makers continue to face more securities fraud lawsuits

Pharmalot Ed Silverman

Drug makers are sued for scheming to illegally fix insulin prices

Pharmalot Ed Silverman

Litigation

Most Read

Pharmalittle: Four drug companies settle Ohio opioid suit; J&J recalls baby powder due to asbestos

FTC warns lawyers about deceptive ads for generating lawsuits over drug side effects

Pharmalittle: Opioid settlements may yield tax breaks for drug makers; EMA probes heartburn meds for carcinogens

Nuclear pharmacies sue a key supplier of radiology medicines for pursuing an ‘illegal monopoly’

Pharmalittle: Trump grows frustrated over drug pricing; FDA enforcement declines under Trump

Pharmalittle: Colorado is first U.S. state to cap insulin prices; JP Morgan cuts ties with Purdue

Baltimore sues a J&J unit over ‘sham’ patent litigation to extend its monopoly on a cancer drug

Generic drug price-fixing suit is akin to earlier case, but ‘on steroids,’ Conn. prosecutor says

All Coverage

A federal appeals court just slammed the door on Allergan’s deal with the Mohawk tribe

Aetna pressures whistleblower who alleged CVS Caremark ripped off Medicare

Pharmalittle: Amgen migraine drug costs less than expected; J&J halts development on Alzheimer’s drug

A reversal of fortunes: Judge voids order Gilead must pay $2.5B to Merck over a patent dispute

Pharmalittle: Supermarkets sue over generic price fixing; Daiichi can collect that $550 million award

Pharmalittle: Sanofi to refund Philippines for dengue vaccine; Google backs universal flu vaccine

Allergan may face a setback to its Mohawk deal thanks to a new ruling

Three more drug makers allegedly used nurses to promote medicines

Pharmalittle: Anthem to start its own PBM; J&J wins a big court reversal

Allergan to pay $4 million to settle sex discrimination charges by former sales reps

Pharmalittle: Shire CFO will be leaving; J&J hit with $417 million talc verdict

Pfizer must face NYU in a lawsuit over royalties on a cancer drug, again

Winners and losers: Who had a good week – and who didn’t

Glaxo fights a lawsuit that has all sorts of interesting twists

Drug makers continue to face more securities fraud lawsuits

Drug makers are sued for scheming to illegally fix insulin prices

Pfizer slammed for banning employee class action complaints

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day